TrimRx vs Ro: Compounded GLP-1 Specialist vs Multi-Vertical Incumbent
TrimRx and Ro are different platform models that overlap on cash-pay compounded GLP-1. TrimRx is our top-rated provider in the compounded specialist cohort: LegitScript-certified, BBB-accredited, no FDA enforcement actions, no active manufacturer lawsuits. Ro is the multi-vertical incumbent (men's health, hair loss, fertility, weight loss under one membership) with a mature insurance concierge for branded Wegovy and Zepbound, plus compounded options through partner pharmacies. The choice usually comes down to whether you have insurance and what kind of platform relationship you want.
TrimRx
4.3LegitScript-certified compounded GLP-1 telehealth
Ro
3.6Established multi-vertical telehealth with insurance concierge for branded GLP-1
Reviewed by Designing Longevity Editorial·Last verified May 1, 2026
Bottom line
If you have commercial insurance covering Wegovy or Zepbound, Ro wins outright on the insurance pathway. The concierge can drop your effective monthly cost to $0-$25 with eligible coverage and a manufacturer savings card, math that no cash-pay specialist can match. If you're cash-pay on compounded GLP-1, TrimRx wins on accreditation depth, regulatory cleanness, and honest per-fill sourcing transparency. Neither is wrong; the deciding question is your coverage situation.
Side-by-side at a glance
Who wins for each use case
We pick a winner per criterion and explain the reasoning. Skip to whichever rows match how you'd actually use the platform.
Insurance pathway for branded GLP-1
Winner: RoRo runs a mature insurance concierge that handles prior authorization for branded Wegovy and Zepbound, with a manufacturer savings card that can drop effective monthly cost to $0-$25 for eligible commercial-insurance users. TrimRx is built around cash-pay compounded GLP-1 and does not run a comparable branded-insurance pathway. If insurance is your route, this row decides the comparison.
Accreditation stack on the compounded line
Winner: TrimRxTrimRx has the strongest accreditation stack in our compounded cohort: LegitScript Healthcare Merchant Certification, BBB-accredited with a B rating, and partner pharmacies that are themselves LegitScript-certified. Ro has BBB Accredited B since 2018 (longer-tenured) but does not name its compounded partner pharmacies per fill or surface comparable per-pharmacy accreditation depth.
Cash-pay pricing on compounded GLP-1
Winner: TrimRxTrimRx is built around all-inclusive cash-pay pricing for compounded semaglutide and tirzepatide. Ro's cash-pay compounded path runs on top of a $145/month membership ($74/month annual prepay), so all-in monthly is meaningfully higher. For users without insurance who specifically want compounded GLP-1, TrimRx is the cleaner cost structure.
Regulatory and legal track record
Winner: TrimRxNeither has an FDA warning letter on the GLP-1 line. TrimRx has no flagged industry-wide events affecting its product mix. Ro is flagged for the April 2025 FDA compounded topical finasteride alert (industry-wide alert, but Ro markets compounded topical finasteride for hair loss, so it's in scope). The hair-loss product line is separate from GLP-1, but it's a softer counterweight on Ro's compounder-vendor management track record.
Per-fill sourcing transparency
Winner: TrimRxTrimRx names LegitScript-certified partner pharmacies with the certification stack documented at the partner level. Ro uses a network of partner compounding pharmacies and does not surface the specific partner per fill. For users who want to know exactly where their compounded medication came from, TrimRx is the more transparent answer.
Multi-vertical platform breadth
Winner: RoRo covers weight loss, men's health, hair loss, fertility, and skincare under one membership model with operations going back to 2017. TrimRx is GLP-1-focused (compounded plus brand-name pathways within that single category). If you want one provider for several health needs, Ro is the obviously broader option.
Customer service and review platform signals
Winner: RoRo has BBB Accredited B since 2018 plus the largest ConsumerAffairs review sample in our cohort (4.4/5 across roughly 21,800 reviews) and Trustpilot 3.7/5 across roughly 3,200 reviews. TrimRx has BBB Accredited B but a smaller external review sample. The review-platform volume and complaint-handling track record favors Ro on this row, even though TrimRx wins on accreditation depth.
Operational maturity
Winner: RoRo's 2017 founding and multi-vertical scale gives it the largest user base in our cohort and the longest BBB tenure. TrimRx is a newer, narrower entrant. Both run mature support, but Ro's operational depth is meaningfully larger on every measurable axis.
Rubric scores side-by-side
Same six dimensions we use on every provider profile, weighted to a single 0-5 score. Click through to either profile for the verification details behind each row.
Licensure 20% weight
Accreditation 20% weight
Transparency 20% weight
Product quality 15% weight
Pricing 15% weight
Customer service 10% weight
Pricing in plain terms
Ro: $45 first month, $145/month standard or $74/month annual prepay, plus medication. With eligible commercial insurance and a Novo Nordisk savings card, branded Wegovy via Ro can drop to $0-$25/month effective cost (the concierge handles prior auth). Without insurance, cash-pay compounded GLP-1 through Ro lands at $200-$400/month medication on top of membership. TrimRx: all-inclusive cash-pay compounded GLP-1 starting at $179/month for semaglutide and $259/month for tirzepatide, no separate membership fee, no insurance pathway. The simplest decision rule: insurance covers Wegovy or Zepbound -> Ro; cash-pay on compounded GLP-1 -> TrimRx.
Read the full profiles
This comparison summarizes the head-to-head call. The full provider profiles include verification items, regulatory history, public-review aggregation, and the signup walkthrough.